Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma

被引:76
|
作者
Sun, Matthew Z. [1 ]
Oh, Taemin [2 ]
Ivan, Michael E. [1 ]
Clark, Aaron J. [1 ]
Safaee, Michael [1 ]
Sayegh, Eli T. [2 ]
Kaur, Gurvinder [2 ]
Parsa, Andrew T. [2 ]
Bloch, Orin [2 ]
机构
[1] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA
[2] Northwestern Univ, Dept Neurol Surg, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
glioblastoma; overall survival; progression-free survival; treatment delay; The Cancer Genome Atlas; oncology; ADJUVANT TEMOZOLOMIDE; WAITING-TIMES; RADIOTHERAPY; DELAY; CONCOMITANT; RADIATION; EORTC;
D O I
10.3171/2014.9.JNS14193
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECT There are few and conflicting reports on the effects of delayed initiation of chemoradiotherapy on the survival of patients with glioblastoma. The standard of care for newly diagnosed glioblastoma is concurrent radiotherapy and temozolomide chemotherapy after maximal safe resection; however, the optimal timing of such therapy is poorly defined. Given the lack of consensus in the literature, the authors performed a retrospective analysis of The Cancer Genome Atlas (TCGA) database to investigate the effect of time from surgery to initiation of therapy on survival in newly diagnosed glioblastoma. METHODS Patients with primary glioblastoma diagnosed since 2005 and treated according to the standard of care were identified from TCGA database. Kaplan-Meier and multivariate Cox regression analyses were used to compare overall survival (OS) and progression-free survival (PFS) between groups stratified by postoperative delay to initiation of radiation treatment. RESULTS There were 218 patients with newly diagnosed glioblastoma with known time to initiation of radiotherapy identified in the database. The median duration until therapy was 27 days. Delay to radiotherapy longer than the median was not associated with worse PFS (HR = 0.918, p = 0.680) or OS (HR = 1.135, p = 0.595) in multivariate analysis when controlling for age, sex, KPS score, and adjuvant chemotherapy. Patients in the highest and lowest quartiles for delay to therapy (<= 20 days vs >= 36 days) did not statistically differ in PFS (p = 0.667) or OS (p = 0.124). The small subset of patients with particularly long delays (>42 days) demonstrated worse OS (HR = 1.835, p = 0.019), but not PFS (p = 0.74). CONCLUSIONS Modest delay in initiation of postoperative chemotherapy and radiation does not appear to be associated with worse PFS or OS in patients with newly diagnosed glioblastoma, while significant delay longer than 6 weeks may be associated with worse OS.
引用
收藏
页码:1144 / 1150
页数:7
相关论文
共 50 条
  • [31] A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy
    Jiayi Huang
    Jian L. Campian
    Amit D. Gujar
    David D. Tran
    A. Craig Lockhart
    Todd A. DeWees
    Christina I. Tsien
    Albert H. Kim
    Journal of Neuro-Oncology, 2016, 128 : 259 - 266
  • [32] Newly Diagnosed Glioblastoma: Delay in Radiation Therapy Initiation Associated With Adverse Socioeconomic Factors and Worse Survival
    Pollom, E.
    Fujimoto, D. K.
    Harris, J. P.
    Chin, A. L.
    Qian, Y.
    Tharin, S.
    Soltys, S. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E100 - E100
  • [33] Impact of postoperative dexamethasone on survival, steroid dependency, and infections in newly diagnosed glioblastoma patients
    Mistry, Akshitkumar M.
    Jonathan, Sumeeth, V
    Monsour, Meredith A.
    Mobley, Bret C.
    Clark, Stephen W.
    Moots, Paul L.
    NEURO-ONCOLOGY PRACTICE, 2021, 8 (05) : 589 - 600
  • [34] Newly diagnosed glioblastoma: adverse socioeconomic factors correlate with delay in radiotherapy initiation and worse overall survival
    Pollom, Erqi L.
    Fujimoto, Dylann K.
    Han, Summer S.
    Harris, Jeremy P.
    Tharin, Suzanne A.
    Soltys, Scott G.
    JOURNAL OF RADIATION RESEARCH, 2018, 59 : I11 - I18
  • [35] Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival
    John, Flora
    Bosnyak, Edit
    Robinette, Natasha L.
    Amit-Yousif, Alit J.
    Barger, Geoffrey R.
    Shah, Keval D.
    Michelhaugh, Sharon K.
    Klinger, Neil V.
    Mittal, Sandeep
    Juhasz, Csaba
    NEURO-ONCOLOGY, 2019, 21 (02) : 264 - 273
  • [36] A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy
    Huang, Jiayi
    Campian, Jian L.
    Gujar, Amit D.
    Tran, David D.
    Lockhart, A. Craig
    DeWees, Todd A.
    Tsien, Christina I.
    Kim, Albert H.
    JOURNAL OF NEURO-ONCOLOGY, 2016, 128 (02) : 259 - 266
  • [37] Peripheral Regulatory T Cells are Expanded but do not Impact Survival in Newly Diagnosed Glioblastoma
    DiDomenico, Joseph D.
    Oyon, Daniel Eduardo
    Choy, Winward
    Lamano, Jonathan B.
    Veliceasa, Dorina
    Ampie, Leonel
    Lamano, Jason
    Bloch, Orin
    NEUROSURGERY, 2017, 64 : 288 - 288
  • [38] CARDIOPULMONARY FITNESS AND NEUROCOGNITION IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH BEVACIZUMAB AND IMPACT ON SURVIVAL
    Peters, Katherine
    Kenjale, Aarti
    West, Miranda
    Hornsby, Whitney
    Herndon, James
    McSherry, Frances
    Desjardins, Annick
    Friedman, Henry
    Jones, Lee
    NEURO-ONCOLOGY, 2013, 15 : 96 - 96
  • [39] Survival Impact of Delaying Postoperative Chemoradiotherapy in Newly Diagnosed High-Grade Glioma Patients
    Zhang, M.
    Xu, F.
    Ni, W.
    Gao, Y.
    Cao, W.
    Chen, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E112 - E113
  • [40] Extent of Resection in Newly Diagnosed Glioblastoma: Impact of a Specialized Neuro-Oncology Care Center
    Haj, Amer
    Doenitz, Christian
    Schebesch, Karl-Michael
    Ehrensberger, Denise
    Hau, Peter
    Putnik, Kurt
    Riemenschneider, Markus J.
    Wendl, Christina
    Gerken, Michael
    Pukrop, Tobias
    Brawanski, Alexander
    Proescholdt, Martin A.
    BRAIN SCIENCES, 2018, 8 (01):